Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review
PurposeWe aimed to perform a retrospective analysis of a rare subtype of corticotroph adenoma, Crooke’s cell adenoma, to better understand its clinical features.MethodsWe collected T-PIT-positive pituitary adenomas and screened Crooke’s cell adenomas from January 2020 to December 2021 in our center....
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Endocrinology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fendo.2022.947085/full |
_version_ | 1811284028872982528 |
---|---|
author | Dimin Zhu Zongming Wang Tian Tian Xinyi Wu Dongsheng He Yonghong Zhu Dawei Liu Haijun Wang |
author_facet | Dimin Zhu Zongming Wang Tian Tian Xinyi Wu Dongsheng He Yonghong Zhu Dawei Liu Haijun Wang |
author_sort | Dimin Zhu |
collection | DOAJ |
description | PurposeWe aimed to perform a retrospective analysis of a rare subtype of corticotroph adenoma, Crooke’s cell adenoma, to better understand its clinical features.MethodsWe collected T-PIT-positive pituitary adenomas and screened Crooke’s cell adenomas from January 2020 to December 2021 in our center. Case reports of such tumors were also collected through a literature search. Clinical data such as biochemical tests, imaging examinations, and pathological data of the above cases were analyzed.ResultsA total of 101 T-PIT-positive patients were treated in our center in the last 2 years, and 4 were finally pathologically diagnosed with Crooke’s cell adenomas. All of these patients were male with elevated adrenocorticotropic hormone levels, and 50.0% presented with hypercortisolemia, Cushing’s syndrome, visual impairment, and headache. The tumor diameter was significantly larger in these 4 patients (37.0 mm) than in the other patients (26.0 mm), and their tumor invasive behavior was more pronounced. Cases reported in the literature were mainly female (72.8%), and the clinical presentation was also dominated by Cushing’s syndrome (65.1%) and hormonal dysfunction. Tumors were more common as macroadenomas (33.2 mm) and suprasellar growths (63.8%). The tumor recurrence rate was as high as 55.6%, with 6 cases progressing to pituitary carcinomas and 7.7% of tumor-related deaths. Our further integrated analysis of our center and reported cases revealed that gender, Cushing’s syndrome, visual dysfunction, hormonal disorders, and tumor growth characteristics were statistically different in different tumor categories.ConclusionCrooke’s cell adenoma is a tumor subtype with obvious clinical aggressive behavior, and an in-depth analysis of its clinical characteristics may assist in developing a comprehensive treatment plan. |
first_indexed | 2024-04-13T02:22:31Z |
format | Article |
id | doaj.art-e51f5b17ddf64af9bc4815a95641ef59 |
institution | Directory Open Access Journal |
issn | 1664-2392 |
language | English |
last_indexed | 2024-04-13T02:22:31Z |
publishDate | 2022-08-01 |
publisher | Frontiers Media S.A. |
record_format | Article |
series | Frontiers in Endocrinology |
spelling | doaj.art-e51f5b17ddf64af9bc4815a95641ef592022-12-22T03:06:55ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-08-011310.3389/fendo.2022.947085947085Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature reviewDimin Zhu0Zongming Wang1Tian Tian2Xinyi Wu3Dongsheng He4Yonghong Zhu5Dawei Liu6Haijun Wang7Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Histology and Embryology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, ChinaDepartment of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaDepartment of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, ChinaPurposeWe aimed to perform a retrospective analysis of a rare subtype of corticotroph adenoma, Crooke’s cell adenoma, to better understand its clinical features.MethodsWe collected T-PIT-positive pituitary adenomas and screened Crooke’s cell adenomas from January 2020 to December 2021 in our center. Case reports of such tumors were also collected through a literature search. Clinical data such as biochemical tests, imaging examinations, and pathological data of the above cases were analyzed.ResultsA total of 101 T-PIT-positive patients were treated in our center in the last 2 years, and 4 were finally pathologically diagnosed with Crooke’s cell adenomas. All of these patients were male with elevated adrenocorticotropic hormone levels, and 50.0% presented with hypercortisolemia, Cushing’s syndrome, visual impairment, and headache. The tumor diameter was significantly larger in these 4 patients (37.0 mm) than in the other patients (26.0 mm), and their tumor invasive behavior was more pronounced. Cases reported in the literature were mainly female (72.8%), and the clinical presentation was also dominated by Cushing’s syndrome (65.1%) and hormonal dysfunction. Tumors were more common as macroadenomas (33.2 mm) and suprasellar growths (63.8%). The tumor recurrence rate was as high as 55.6%, with 6 cases progressing to pituitary carcinomas and 7.7% of tumor-related deaths. Our further integrated analysis of our center and reported cases revealed that gender, Cushing’s syndrome, visual dysfunction, hormonal disorders, and tumor growth characteristics were statistically different in different tumor categories.ConclusionCrooke’s cell adenoma is a tumor subtype with obvious clinical aggressive behavior, and an in-depth analysis of its clinical characteristics may assist in developing a comprehensive treatment plan.https://www.frontiersin.org/articles/10.3389/fendo.2022.947085/fullCrooke’s cellpituitary adenomaACTHCushing diseasehyalinization |
spellingShingle | Dimin Zhu Zongming Wang Tian Tian Xinyi Wu Dongsheng He Yonghong Zhu Dawei Liu Haijun Wang Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review Frontiers in Endocrinology Crooke’s cell pituitary adenoma ACTH Cushing disease hyalinization |
title | Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review |
title_full | Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review |
title_fullStr | Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review |
title_full_unstemmed | Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review |
title_short | Prevalence and clinical characteristics of Crooke’s cell adenomas in 101 patients with T-PIT-positive pituitary adenomas: Case series and literature review |
title_sort | prevalence and clinical characteristics of crooke s cell adenomas in 101 patients with t pit positive pituitary adenomas case series and literature review |
topic | Crooke’s cell pituitary adenoma ACTH Cushing disease hyalinization |
url | https://www.frontiersin.org/articles/10.3389/fendo.2022.947085/full |
work_keys_str_mv | AT diminzhu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT zongmingwang prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT tiantian prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT xinyiwu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT dongshenghe prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT yonghongzhu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT daweiliu prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview AT haijunwang prevalenceandclinicalcharacteristicsofcrookescelladenomasin101patientswithtpitpositivepituitaryadenomascaseseriesandliteraturereview |